Dubai: Emirates Health Services (EHS) has announced the availability of BYANNLI, a long-acting schizophrenia treatment developed by Johnson & Johnson, at Al Amal Psychiatric Hospital, making it the first government hospital in the UAE to offer the innovative therapy.BYANNLI is administered once every six months, representing one of the latest advances in the treatment and management of schizophrenia.Dr Essam Al Zarooni, Executive Director of the…